Page last updated: 2024-08-23

raloxifene hydrochloride and Hepatitis C, Chronic

raloxifene hydrochloride has been researched along with Hepatitis C, Chronic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Furusyo, N; Hayashi, J; Hayashi, T; Hiramine, S; Ihara, T; Ikezaki, H; Kainuma, M; Kajiwara, E; Mukae, H; Murata, M; Ogawa, E; Okada, K; Sudoh, M; Taniai, H; Toyoda, K	1

Trials

1 trial(s) available for raloxifene hydrochloride and Hepatitis C, Chronic

Article	Year
Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial. Journal of hepatology, 2012, Volume: 57, Issue:6 Topics: Adjuvants, Pharmaceutic; Aged; Antiviral Agents; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Middle Aged; Polyethylene Glycols; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Recombinant Proteins; Ribavirin; RNA, Viral; Selective Estrogen Receptor Modulators	2012

Article

Year

Raloxifene hydrochloride is an adjuvant antiviral treatment of postmenopausal women with chronic hepatitis C: a randomized trial.

Journal of hepatology, 2012, Volume: 57, Issue:6

Topics: Adjuvants, Pharmaceutic; Aged; Antiviral Agents; Female; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Middle Aged; Polyethylene Glycols; Postmenopause; Prospective Studies; Raloxifene Hydrochloride; Recombinant Proteins; Ribavirin; RNA, Viral; Selective Estrogen Receptor Modulators

2012